High Court To Hear Merck Bid In Vioxx Class Action
In the latest twist in the long-running saga over Merck & Co.'s recalled painkiller Vioxx, the U.S. Supreme Court has agreed to consider the pharmaceutical giant's appeal of a lower court...To view the full article, register now.
Already a subscriber? Click here to view full article